Allogenic hematopoietic cell transplant a viable option for high-risk myelodysplastic syndrome, study suggests
byDana-Farber Cancer InstituteClinical outcomes by TP53 allelic state. (A) OS by TP53 allelic state. (B) Cumulative incidence of MDS relapse or progression to AML by TP53 allelic state, with dea
Updated on: January 16,2024
Allogenic hematopoietic cell transplant a viable option for high-risk myelodysplastic syndrome, study suggests
byDana-Farber Cancer InstituteClinical outcomes by TP53 allelic state. (A) OS by TP53 allelic state. (B) Cumulative incidence of MDS relapse or progression to AML by TP53 allelic state, with dea
Updated on:January 16,2024
